Satsuma Pharmaceuticals, Inc.

NasdaqGM:STSA Stock Report

Market Cap: US$36.5m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Satsuma Pharmaceuticals Future Growth

Future criteria checks 2/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Satsuma Pharmaceuticals.

Key information

54.7%

Earnings growth rate

68.6%

EPS growth rate

Pharmaceuticals earnings growth21.5%
Revenue growth rate60.3%
Future return on equityn/a
Analyst coverage

Low

Last updated19 May 2023

Recent future growth updates

Recent updates

Can Satsuma Pharmaceuticals (NASDAQ:STSA) Afford To Invest In Growth?

Feb 15
Can Satsuma Pharmaceuticals (NASDAQ:STSA) Afford To Invest In Growth?

Will Satsuma Pharmaceuticals (NASDAQ:STSA) Spend Its Cash Wisely?

Sep 02
Will Satsuma Pharmaceuticals (NASDAQ:STSA) Spend Its Cash Wisely?

Here's Why We're Watching Satsuma Pharmaceuticals' (NASDAQ:STSA) Cash Burn Situation

May 13
Here's Why We're Watching Satsuma Pharmaceuticals' (NASDAQ:STSA) Cash Burn Situation

Satsuma Pharmaceuticals: Sizing Up This One Trick Pony

Nov 07

Satsuma shares surge on data from early-stage STS101 trial

Jun 16

Do Institutions Own Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) Shares?

Jan 26
Do Institutions Own Satsuma Pharmaceuticals, Inc. (NASDAQ:STSA) Shares?

Earnings and Revenue Growth Forecasts

NasdaqGM:STSA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202511-20N/AN/A4
12/31/20243-22N/AN/A4
12/31/2023N/A-25N/AN/A4
3/31/2023N/A-65-49-49N/A
12/31/2022N/A-70-52-52N/A
9/30/2022N/A-62-53-53N/A
6/30/2022N/A-61-50-49N/A
3/31/2022N/A-56-50-49N/A
12/31/2021N/A-51-45-43N/A
9/30/2021N/A-48-44-38N/A
6/30/2021N/A-47-45-39N/A
3/31/2021N/A-46-44-38N/A
12/31/2020N/A-48-47-42N/A
9/30/2020N/A-46-42-41N/A
6/30/2020N/A-42-42-42N/A
3/31/2020N/A-37-40-40N/A
12/31/2019N/A-28-30-30N/A
9/30/2019N/A-20-25-24N/A
6/30/2019N/A-13-15-14N/A
3/31/2019N/A-8-8-8N/A
12/31/2018N/A-7-7-7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: STSA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: STSA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: STSA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: STSA's revenue (60.3% per year) is forecast to grow faster than the US market (7.3% per year).

High Growth Revenue: STSA's revenue (60.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if STSA's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.